Methylphenidate Hydrochloride Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 50 pharmaceutical companies such as TRIS PHARMA INC, SANDOZ, DR REDDYS LABS SA and others. It is marketed under 11 brand names, including METHYLPHENIDATE HYDROCHLORIDE, FOCALIN XR, QUILLIVANT XR and others. Available in 29 different strengths, such as 5MG/5ML, 10MG/5ML, 40MG and others, and administered through 8 routes including SOLUTION;ORAL, CAPSULE, EXTENDED RELEASE;ORAL, TABLET;ORAL and others.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 50 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"57910","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLICHEW ER","family_id":"ab746e06a067453e8066","publication_number":"US8202537B2","cleaned_patent_number":"8202537","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-03-15","publication_date":"2012-06-19","legal_status":"Granted"} US8202537B2 Formulation 19 Jun, 2012 Granted 15 Mar, 2027
{"application_id":"57892","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLIVANT XR","family_id":"ab746e06a067453e8066","publication_number":"US8062667B2","cleaned_patent_number":"8062667","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-03-29","publication_date":"2011-11-22","legal_status":"Granted"} US8062667B2 Formulation 22 Nov, 2011 Granted 29 Mar, 2029
{"application_id":"57874","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLIVANT XR","family_id":"51d24ff7d5bc437dbbaa","publication_number":"US8465765B2","cleaned_patent_number":"8465765","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-02-15","publication_date":"2013-06-18","legal_status":"Granted"} US8465765B2 Formulation 18 Jun, 2013 Granted 15 Feb, 2031
{"application_id":"57883","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLICHEW ER","family_id":"51d24ff7d5bc437dbbaa","publication_number":"US8287903B2","cleaned_patent_number":"8287903","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-02-15","publication_date":"2012-10-16","legal_status":"Granted"} US8287903B2 Formulation 16 Oct, 2012 Granted 15 Feb, 2031
{"application_id":"57887","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLIVANT XR","family_id":"51d24ff7d5bc437dbbaa","publication_number":"US9040083B2","cleaned_patent_number":"9040083","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-02-15","publication_date":"2015-05-26","legal_status":"Granted"} US9040083B2 Formulation 26 May, 2015 Granted 15 Feb, 2031
{"application_id":"57885","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLIVANT XR","family_id":"51d24ff7d5bc437dbbaa","publication_number":"US8778390B2","cleaned_patent_number":"8778390","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-02-15","publication_date":"2014-07-15","legal_status":"Granted"} US8778390B2 Formulation 15 Jul, 2014 Granted 15 Feb, 2031
{"application_id":"57886","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLIVANT XR","family_id":"51d24ff7d5bc437dbbaa","publication_number":"US8956649B2","cleaned_patent_number":"8956649","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-02-15","publication_date":"2015-02-17","legal_status":"Patented case"} US8956649B2 Formulation 17 Feb, 2015 Patented case 15 Feb, 2031
{"application_id":"57884","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLIVANT XR","family_id":"51d24ff7d5bc437dbbaa","publication_number":"US8563033B1","cleaned_patent_number":"8563033","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-02-15","publication_date":"2013-10-22","legal_status":"Granted"} US8563033B2 Formulation 22 Oct, 2013 Granted 15 Feb, 2031
{"application_id":"44470","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US9023389B1","cleaned_patent_number":"9023389","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2015-05-05","legal_status":"Granted"} US9023389B2 Formulation 05 May, 2015 Granted 23 Mar, 2032
{"application_id":"44443","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US8927010B2","cleaned_patent_number":"8927010","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2015-01-06","legal_status":"Granted"} US8927010B2 Formulation 06 Jan, 2015 Granted 23 Mar, 2032
{"application_id":"44442","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US8916588B2","cleaned_patent_number":"8916588","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2014-12-23","legal_status":"Granted"} US8916588B2 23 Dec, 2014 Granted 23 Mar, 2032
{"application_id":"44457","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US10617651B2","cleaned_patent_number":"10617651","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2020-04-14","legal_status":"Granted"} US10617651B2 14 Apr, 2020 Granted 23 Mar, 2032
{"application_id":"44455","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US10182995B2","cleaned_patent_number":"10182995","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2019-01-22","legal_status":"Granted"} US10182995B2 Formulation 22 Jan, 2019 Granted 23 Mar, 2032
{"application_id":"44458","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US10881618B2","cleaned_patent_number":"10881618","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2021-01-05","legal_status":"Patented case"} US10881618B2 05 Jan, 2021 Patented case 23 Mar, 2032
{"application_id":"44459","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US10905652B2","cleaned_patent_number":"10905652","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2021-02-02","legal_status":"Granted"} US10905652B2 Formulation 02 Feb, 2021 Granted 23 Mar, 2032
{"application_id":"44452","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US9603809B2","cleaned_patent_number":"9603809","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2017-03-28","legal_status":"Granted"} US9603809B2 28 Mar, 2017 Granted 23 Mar, 2032
{"application_id":"44460","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US11241391B2","cleaned_patent_number":"11241391","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2022-02-08","legal_status":"Granted"} US11241391B2 08 Feb, 2022 Granted 23 Mar, 2032
{"application_id":"44461","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US11241392B2","cleaned_patent_number":"11241392","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2022-02-08","legal_status":"Granted"} US11241392B2 Formulation 08 Feb, 2022 Granted 23 Mar, 2032
{"application_id":"44449","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US9498447B2","cleaned_patent_number":"9498447","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2016-11-22","legal_status":"Granted"} US9498447B2 Formulation 22 Nov, 2016 Granted 23 Mar, 2032
{"application_id":"44463","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US11911518B2","cleaned_patent_number":"11911518","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2024-02-27","legal_status":"Granted"} US11911518B2 27 Feb, 2024 Granted 23 Mar, 2032
{"application_id":"44447","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US9283214B2","cleaned_patent_number":"9283214","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2016-03-15","legal_status":"Granted"} US9283214B2 Formulation 15 Mar, 2016 Granted 23 Mar, 2032
{"application_id":"44414","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US9034902B2","cleaned_patent_number":"9034902","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2015-05-19","legal_status":"Granted"} US9034902B2 19 May, 2015 Granted 23 Mar, 2032
{"application_id":"44445","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US9028868B2","cleaned_patent_number":"9028868","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2015-05-12","legal_status":"Granted"} US9028868B2 12 May, 2015 Granted 23 Mar, 2032
{"application_id":"44456","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"JORNAY PM","family_id":"c9bdd29f785744a2a763","publication_number":"US10292937B2","cleaned_patent_number":"10292937","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-23","publication_date":"2019-05-21","legal_status":"Granted"} US10292937B2 21 May, 2019 Granted 23 Mar, 2032
{"application_id":"45892","ingredient":"DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE","trade_name":"AZSTARYS","family_id":"6d1cd10785284e81b2c6","publication_number":"US9079928B2","cleaned_patent_number":"9079928","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-07-27","publication_date":"2015-07-14","legal_status":"Granted"} US9079928B2 Formulation 14 Jul, 2015 Granted 27 Jul, 2032
{"application_id":"84459","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLICHEW ER","family_id":"a7d0f235f54747aeb1d2","publication_number":"US9545399B2","cleaned_patent_number":"9545399","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-08-14","publication_date":"2017-01-17","legal_status":"Granted"} US9545399B2 Formulation 17 Jan, 2017 Granted 14 Aug, 2033
{"application_id":"84473","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLICHEW ER","family_id":"a7d0f235f54747aeb1d2","publication_number":"US10857143B2","cleaned_patent_number":"10857143","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-08-14","publication_date":"2020-12-08","legal_status":"Granted"} US10857143B2 Formulation 08 Dec, 2020 Granted 14 Aug, 2033
{"application_id":"84474","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLICHEW ER","family_id":"a7d0f235f54747aeb1d2","publication_number":"US11103494B2","cleaned_patent_number":"11103494","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-08-14","publication_date":"2021-08-31","legal_status":"Granted"} US11103494B2 Formulation 31 Aug, 2021 Granted 14 Aug, 2033
{"application_id":"84475","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLICHEW ER","family_id":"a7d0f235f54747aeb1d2","publication_number":"US11103495B2","cleaned_patent_number":"11103495","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-08-14","publication_date":"2021-08-31","legal_status":"Granted"} US11103495B2 Formulation 31 Aug, 2021 Granted 14 Aug, 2033
{"application_id":"84479","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLICHEW ER","family_id":"146109db664e4801a456","publication_number":"US11633389B2","cleaned_patent_number":"11633389","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-08-14","publication_date":"2023-04-25","legal_status":"Granted"} US11633389B2 Formulation 25 Apr, 2023 Granted 14 Aug, 2033
{"application_id":"84467","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLICHEW ER","family_id":"a7d0f235f54747aeb1d2","publication_number":"US8999386B2","cleaned_patent_number":"8999386","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-08-14","publication_date":"2015-04-07","legal_status":"Granted"} US8999386B2 Formulation 07 Apr, 2015 Granted 14 Aug, 2033
{"application_id":"84469","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLICHEW ER","family_id":"a7d0f235f54747aeb1d2","publication_number":"US9295642B2","cleaned_patent_number":"9295642","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-08-14","publication_date":"2016-03-29","legal_status":"Granted"} US9295642B2 Formulation 29 Mar, 2016 Granted 14 Aug, 2033
{"application_id":"84470","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"QUILLICHEW ER","family_id":"a7d0f235f54747aeb1d2","publication_number":"US9844544B2","cleaned_patent_number":"9844544","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-08-14","publication_date":"2017-12-19","legal_status":"Granted"} US9844544B2 Formulation 19 Dec, 2017 Granted 14 Aug, 2033
{"application_id":"44083","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"ADHANSIA XR","family_id":"787ddc9a53f74643a49f","publication_number":"US10111839B2","cleaned_patent_number":"10111839","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-30","publication_date":"2018-10-30","legal_status":"Patented case"} US10111839B2 30 Oct, 2018 Patented case 30 Oct, 2035
{"application_id":"44114","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"ADHANSIA XR","family_id":"787ddc9a53f74643a49f","publication_number":"US10507186B2","cleaned_patent_number":"10507186","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-30","publication_date":"2019-12-17","legal_status":"Granted"} US10507186B2 Formulation 17 Dec, 2019 Granted 30 Oct, 2035
{"application_id":"44113","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"ADHANSIA XR","family_id":"787ddc9a53f74643a49f","publication_number":"US10500162B2","cleaned_patent_number":"10500162","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-30","publication_date":"2019-12-10","legal_status":"Granted"} US10500162B2 10 Dec, 2019 Granted 30 Oct, 2035
{"application_id":"44112","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"ADHANSIA XR","family_id":"787ddc9a53f74643a49f","publication_number":"US10449159B2","cleaned_patent_number":"10449159","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-30","publication_date":"2019-10-22","legal_status":"Granted"} US10449159B2 22 Oct, 2019 Granted 30 Oct, 2035
{"application_id":"44111","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"ADHANSIA XR","family_id":"787ddc9a53f74643a49f","publication_number":"US10292939B2","cleaned_patent_number":"10292939","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-30","publication_date":"2019-05-21","legal_status":"Granted"} US10292939B2 Formulation 21 May, 2019 Granted 30 Oct, 2035
{"application_id":"44110","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"ADHANSIA XR","family_id":"787ddc9a53f74643a49f","publication_number":"US10292938B2","cleaned_patent_number":"10292938","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-30","publication_date":"2019-05-21","legal_status":"Granted"} US10292938B2 Formulation 21 May, 2019 Granted 30 Oct, 2035
{"application_id":"44118","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"ADHANSIA XR","family_id":"787ddc9a53f74643a49f","publication_number":"US10688060B2","cleaned_patent_number":"10688060","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-30","publication_date":"2020-06-23","legal_status":"Granted"} US10688060B2 Formulation 23 Jun, 2020 Granted 30 Oct, 2035
{"application_id":"44117","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"ADHANSIA XR","family_id":"787ddc9a53f74643a49f","publication_number":"US10568841B2","cleaned_patent_number":"10568841","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-30","publication_date":"2020-02-25","legal_status":"Granted"} US10568841B2 Formulation 25 Feb, 2020 Granted 30 Oct, 2035
{"application_id":"44109","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"ADHANSIA XR","family_id":"787ddc9a53f74643a49f","publication_number":"US9974752B2","cleaned_patent_number":"9974752","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-30","publication_date":"2018-05-22","legal_status":"Granted"} US9974752B2 Formulation 22 May, 2018 Granted 30 Oct, 2035
{"application_id":"44116","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"ADHANSIA XR","family_id":"787ddc9a53f74643a49f","publication_number":"US10512613B2","cleaned_patent_number":"10512613","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-30","publication_date":"2019-12-24","legal_status":"Granted"} US10512613B2 24 Dec, 2019 Granted 30 Oct, 2035
{"application_id":"44115","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"ADHANSIA XR","family_id":"787ddc9a53f74643a49f","publication_number":"US10512612B2","cleaned_patent_number":"10512612","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-30","publication_date":"2019-12-24","legal_status":"Granted"} US10512612B2 Formulation 24 Dec, 2019 Granted 30 Oct, 2035
{"application_id":"138526","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"RELEXXII","family_id":"","publication_number":"US9707217B1","cleaned_patent_number":"9707217","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-03","publication_date":"2017-07-18","legal_status":"Granted"} US9707217B2 Formulation 18 Jul, 2017 Granted 03 Feb, 2037
{"application_id":"138525","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"RELEXXII","family_id":"","publication_number":"US9827234B1","cleaned_patent_number":"9827234","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-03","publication_date":"2017-11-28","legal_status":"Patented Case"} US9827234B2 28 Nov, 2017 Patented Case 03 Feb, 2037
{"application_id":"138522","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"RELEXXII","family_id":"","publication_number":"US10695336B2","cleaned_patent_number":"10695336","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-03","publication_date":"2020-06-30","legal_status":"Granted"} US10695336B2 30 Jun, 2020 Granted 03 Feb, 2037
{"application_id":"138523","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"RELEXXII","family_id":"","publication_number":"US10265308B2","cleaned_patent_number":"10265308","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-03","publication_date":"2019-04-23","legal_status":"Granted"} US10265308B2 Formulation 23 Apr, 2019 Granted 03 Feb, 2037
{"application_id":"138524","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"RELEXXII","family_id":"","publication_number":"US9855258B1","cleaned_patent_number":"9855258","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-03","publication_date":"2018-01-02","legal_status":"Granted"} US9855258B2 Formulation 02 Jan, 2018 Granted 03 Feb, 2037
{"application_id":"45879","ingredient":"DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE","trade_name":"AZSTARYS","family_id":"1e62b8971b6d4008a751","publication_number":"US10759778B2","cleaned_patent_number":"10759778","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-12-09","publication_date":"2020-09-01","legal_status":"Granted"} US10759778B2 Formulation 01 Sep, 2020 Granted 09 Dec, 2037
{"application_id":"45878","ingredient":"DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE","trade_name":"AZSTARYS","family_id":"1e62b8971b6d4008a751","publication_number":"US10584113B2","cleaned_patent_number":"10584113","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-12-09","publication_date":"2020-03-10","legal_status":"Granted"} US10584113B2 Formulation 10 Mar, 2020 Granted 09 Dec, 2037
{"application_id":"45877","ingredient":"DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE","trade_name":"AZSTARYS","family_id":"1e62b8971b6d4008a751","publication_number":"US10584112B2","cleaned_patent_number":"10584112","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-12-09","publication_date":"2020-03-10","legal_status":"Granted"} US10584112B2 Molecular Formulation 10 Mar, 2020 Granted 09 Dec, 2037
{"application_id":"45881","ingredient":"DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE","trade_name":"AZSTARYS","family_id":"1e62b8971b6d4008a751","publication_number":"US10954213B2","cleaned_patent_number":"10954213","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-12-09","publication_date":"2021-03-23","legal_status":"Granted"} US10954213B2 23 Mar, 2021 Granted 09 Dec, 2037
{"application_id":"45865","ingredient":"DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE","trade_name":"AZSTARYS","family_id":"1e62b8971b6d4008a751","publication_number":"US10858341B2","cleaned_patent_number":"10858341","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-12-09","publication_date":"2020-12-08","legal_status":"Granted"} US10858341B2 08 Dec, 2020 Granted 09 Dec, 2037
{"application_id":"44124","ingredient":"METHYLPHENIDATE HYDROCHLORIDE","trade_name":"ADHANSIA XR","family_id":"ead742b971404732a89c","publication_number":"US10722473B2","cleaned_patent_number":"10722473","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-11-19","publication_date":"2020-07-28","legal_status":"Granted"} US10722473B2 28 Jul, 2020 Granted 19 Nov, 2038

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Methylphenidate Hydrochloride

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.